Imodium Original (Loperamide Hydrochloride)

Loperamide hydrochloride acts as a peripheral μ‑opioid receptor agonist in the gut. By binding these receptors, it inhibits the release of acetylcholine and other neurotransmitters, decreasing peristalsis and allowing more time for water and electrolytes to be absorbed, resulting in firmer stools.

The appropriate dose of Imodium Original is determined by a prescriber or according to the product label. Typically, an initial dose is followed by additional doses based on the severity of symptoms, but exact dosing should always be confirmed by a healthcare professional.

Safety data for loperamide in pregnancy and lactation are limited. Healthcare providers usually weigh the benefits against potential risks before recommending use. Women who are pregnant or breastfeeding should discuss alternatives and any possible exposure with their physician.

To place an order, submit an enquiry on the Imodium Original product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Imodium Original (loperamide) is a peripheral μ‑opioid agonist, whereas alternatives such as diphenoxylate‑atropine combine opioid activity with anticholinergic effects. Loperamide generally has a lower risk of central opioid side effects and is available without prescription in many regions, making it a convenient first‑line option.

Store Imodium Original at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

Imodium Original is taken orally, usually as a tablet swallowed whole with water. The tablet should be taken as directed by a healthcare professional or according to the label instructions, and it can be taken with or without food.

Serious risks include severe constipation leading to paralytic ileus, toxic megacolon in patients with underlying inflammatory bowel disease, and rare cardiac arrhythmias such as QT prolongation, especially when combined with other QT‑prolonging drugs.

Imodium Original should be avoided in individuals with known hypersensitivity to loperamide, in cases of bacterial dysentery with fever or blood in stool, in children under two years of age, and in patients with severe hepatic impairment unless specifically advised by a physician.